Epidermal Langerhans cells tune skin reactivity to contact allergens

Journal of Clinical Investigation

Volumn 122, Issue 5, 2012, Pages 1602-1605

  Udey, Mark C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACT ALLERGEN;

CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTACT DERMATITIS; DENDRITIC CELL; EPIDERMIS CELL; HUMAN; IMMUNE RESPONSE; LANGERHANS CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; SKIN ALLERGY; SKIN MANIFESTATION; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DERMATITIS, ALLERGIC CONTACT; FORKHEAD TRANSCRIPTION FACTORS; LANGERHANS CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84860595327     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63190     Document Type: Note

References (23)

1. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic disease. J Clin Invest. 2012;122(2):440-447.
2. Cashman MW, Reutemann PA, Ehrlich A. Contact dermatitis in the United States: Epidemiology, economic impact, and workplace prevention. Dermatol Clin. 2012;30(1):87-98.
3. Kaplan DH, Igyarto BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nature Rev Immunol. 2012;12(2):114-124.
4. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Rev Immunol. 2008;8(12):935-947.
5. Guilliams M, et al. DC lineage and subsets. Eur J Immunol. 2010;40(8):2085-2130.
6. Henri S, et al. Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol. 2010;88(4):366-375.
7. Bennett CL, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol. 2005;169(4):569-576. (Pubitemid 41002850)
8. Kissenpfennig A, et al. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654. (Pubitemid 40719199)
9. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity. 2005;23(6):611-620. (Pubitemid 41779483)
10. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol. 2008; 38(9):2369-2376.
11. Igyarto BZ, et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and Langerhans cell-derived IL-10. J Immunol. 2009;183(8):5085-5093.
12. Obhrai JS, et al. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol. 2008;128(8):1950-1955. (Pubitemid 352001229)
13. Bursch LS, Rich BE, Hogquist KA. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J Immunol. 2009;182(8):4657-4664.
14. Li H, et al. Langerhans cells are not required for graft-versus-host disease. Blood. 2011;117(2):697-707.
15. Allan RS, et al. Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science. 2003;301(5641):1925-1928. (Pubitemid 37229056)
16. Kautz-Neu K, et al. Langerhans cells are negative regulators of the anti-Leischmania response. J Exp Med. 2011;208(5):885-8891.
17. Igyarto BZ, et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity. 2011;35(2):260-272.
18. Nagao K, et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A. 2009;106(9):3312-3317.
19. Ouchi T, et al. Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. J Exp Med. 2011;208(13):2607-2613.
20. Gomez de Agüero M, et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8+ T cells and activating Foxp3+ regulatory T cells. J Clin Invest. 2012;122(5):1700-1711.
21. Dearman RJ, Cumberbatch M, Hilton J, Fielding H, Basketter KI. A re-appraisal of skin-sensitizing activity of 2, 4-dinitrothiocyanobenzene. Food Chem Toxicol. 1997;35(2):261-269.
22. Iijima M, Katz SI. Specific immunologic tolerance to dinitroflurobenzene following topical application of dinitrothicyanobezene: Modulation by suppressor T cells. J Invest Dermatol. 1983;81(4):325-330. (Pubitemid 13013576)
23. Watanabe H, et al. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol. 2008; 180(9):5826-5832.